These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 35997952
1. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries. Kante B, Vuyyuru SK, Kedia S, Sahu P, Kumar P, Ranjan MK, Virmani S, Sharma R, Madhusudhan KS, Panwar R, Das P, Makharia G, Ahuja V. Indian J Gastroenterol; 2022 Aug; 41(4):343-351. PubMed ID: 35997952 [Abstract] [Full Text] [Related]
2. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study. González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L. J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164 [Abstract] [Full Text] [Related]
3. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience. Suárez Ferrer C, González-Lama Y, González-Partida I, Calvo Moya M, Vera Mendoza I, Matallana Royo V, Arevalo Serrano J, Abreu Garcia L. Dig Dis Sci; 2019 Mar; 64(3):875-879. PubMed ID: 30542812 [Abstract] [Full Text] [Related]
4. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease. Vuyyuru SK, Kante B, Kumar P, Sahu P, Kedia S, Ranjan MK, Sharma R, Panwar R, Makharia G, Ahuja V. Sci Rep; 2021 Jun 03; 11(1):11704. PubMed ID: 34083575 [Abstract] [Full Text] [Related]
5. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK. Cochrane Database Syst Rev; 2015 Oct 30; 2015(10):CD000067. PubMed ID: 26517527 [Abstract] [Full Text] [Related]
6. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK. Cochrane Database Syst Rev; 2019 Aug 06; 8(8):CD010233. PubMed ID: 31425621 [Abstract] [Full Text] [Related]
7. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. Rodríguez-Lago I, Hoyo JD, Pérez-Girbés A, Garrido-Marín A, Casanova MJ, Chaparro M, Fernández-Clotet A, Castro-Poceiro J, García MJ, Sánchez S, Ferreiro-Iglesias R, Bastón I, Piqueras M, Careda LEIB, Mena R, Suárez C, Cordón JP, López-García A, Márquez L, Arroyo M, Alfambra E, Sierra M, Cano N, Delgado-Guillena P, Morales-Alvarado V, Aparicio JC, Guerra I, Aulló C, Merino O, Arranz L, Hidalgo MA, Llaó J, Plaza R, Molina G, Torres P, Pérez-Galindo P, Romero MG, Herrera-deGuise C, Armesto E, Mesonero F, Frago-Larramona S, Benítez JM, Calvo M, Martín MDCL, Elorza A, Larena A, Peña E, Rodríguez-Grau MDC, Miguel-Criado J, Botella B, Olmos JA, López L, Aguirre U, Gisbert JP, Young GETECCU Group. United European Gastroenterol J; 2020 Nov 06; 8(9):1056-1066. PubMed ID: 32723069 [Abstract] [Full Text] [Related]
8. Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM. Inflamm Bowel Dis; 2011 Oct 06; 17(10):2138-43. PubMed ID: 21910176 [Abstract] [Full Text] [Related]
9. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet. BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737 [Abstract] [Full Text] [Related]
10. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study. Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF. J Gastroenterol Hepatol; 2007 Feb 01; 22(2):268-74. PubMed ID: 17295882 [Abstract] [Full Text] [Related]
11. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. Gökbulut V, Özin Y, Kalkan İH, Arı D, Yüksel M, Kılıç ZMY, Kayaçetin E. Turk J Gastroenterol; 2022 Feb 01; 33(2):111-118. PubMed ID: 35115294 [Abstract] [Full Text] [Related]
12. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H. Am J Gastroenterol; 2001 Mar 01; 96(3):782-7. PubMed ID: 11280551 [Abstract] [Full Text] [Related]
13. Phenotypic features of Crohn's disease associated with failure of medical treatment. Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R, Alberta Inflammatory Bowel Disease Consortium. Clin Gastroenterol Hepatol; 2014 Mar 01; 12(3):434-42.e1. PubMed ID: 23978351 [Abstract] [Full Text] [Related]
14. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience. Magro F, Santos-Antunes J, Vilas-Boas F, Rodrigues-Pinto E, Coelho R, Ribeiro OS, Lopes S, Macedo G. J Crohns Colitis; 2014 Jul 01; 8(7):617-25. PubMed ID: 24332869 [Abstract] [Full Text] [Related]
15. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study. Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P. J Crohns Colitis; 2015 Apr 01; 9(4):305-11. PubMed ID: 25656249 [Abstract] [Full Text] [Related]
16. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF, Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Gastroenterology; 2013 Oct 01; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079 [Abstract] [Full Text] [Related]
17. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P. Inflamm Bowel Dis; 2009 Mar 01; 15(3):375-82. PubMed ID: 19009634 [Abstract] [Full Text] [Related]
18. Methotrexate for induction of remission in refractory Crohn's disease. McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598 [Abstract] [Full Text] [Related]
19. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease. Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A. BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458 [Abstract] [Full Text] [Related]
20. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM. Inflamm Bowel Dis; 2006 Nov 12; 12(11):1053-7. PubMed ID: 17075346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]